Page 49 - Read Online

42. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed McCarthy WH, Thompson JF. Determinants of outcome in melanoma
PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih patients with cerebral metastases. J Clin Oncol 2004;22:1293-300.
HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, 57. Ranasinghe MG, Sheehan JM. Surgical management of brain
Sperduto CM, Lin N, Mehta M. Effect of tumor subtype on survival metastases. Neurosurg Focus 2007;22:E2.
and the graded prognostic assessment for patients with breast cancer 58. Eisner W, Burtscher J, Bale R, Sweeney R, Koppelstatter F,
and brain metastases. Int J Radiat Oncol Biol Phys 2012;82:2111-7. Golaszewski S, Kolbitsch C, Twerdy K. Use of neuronavigation and
43. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed electrophysiology in surgery of subcortically located lesions in the
PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih sensorimotor strip. J Neurol Neurosurg Psychiatry 2002;72:378-8.
HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, 59. Unsgaard G, Selbekk T, Brostrup Muller T, Ommedal S, Torp SH,
Sperduto CM, Lin N, Mehta M. Summary report on the graded Myhr G, Bang J, Nagelhus Hernes TA. Ability of navigated 3D
prognostic assessment: an accurate and facile diagnosis-specific tool ultrasound to delineate gliomas and metastases--comparison of
to estimate survival for patients with brain metastases. J Clin Oncol image interpretations with histopathology. Acta Neurochir (Wien)
2012;30:419-25. 2005;147:1259-69;discussion 1269.
44. Herrlinger U, Forschler H, Kuker W, Meyermann R, Bamberg M, 60. Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger HJ, Reifenberger
Dichgans J, Weller M. Leptomeningeal metastasis: survival and G, Sabel M. 5-aminolevulinic acid (5-ALA)-induced fluorescence
prognostic factors in 155 patients. J Neurol Sci 2004;223:167-78. in intracerebral metastases: a retrospective study. Acta Neurochir
45. Chamberlain MC, Johnston SK, Glantz MJ. Neoplastic meningitis- (Wien) 2012;154:223-8;discussion 228.
related prognostic significance of the Karnofsky performance status. 61. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio
Arch Neurol 2009;66:74-8. RJ, Markesbery WR, Macdonald JS, Young B. A Randomized Trial
46. Jaeckle KA. Neoplastic meningitis from systemic malignancies: of Surgery in the Treatment of Single Metastases to the Brain. N Engl
diagnosis, prognosis and treatment. Semin Oncol 2006;33:312-23. J Med 1990 22;322:494-500.
47. Venur VA, Ahluwalia MS. Prognostic scores for brain metastasis 62. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen
patients: use in clinical practice and trial design. Chin Clin Oncol JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff
2015;4:18. AR, Ronald Brand, Jo Hermans.Treatment of single brain metastasis:
48. Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, Bostroem radiotherapy alone or combined with neurosurgery? Ann Neurol
A, Heese O, Koelbl O, Garbe C, Schadendorf D. Number of 1993;33:583-90.
metastases, serum lactate dehydrogenase level, and type of treatment 63. Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of
are prognostic factors in patients with brain metastases of malignant multiple brain metastases. J Neurosurg 1993;79:210-6.
melanoma. Cancer 2011;117:1697-703. 64. Stark AM, Tscheslog H, Buhl R, Held-Feindt J, Mehdorn HM.
49. Marcus DM, Lowe M, Khan MK, Lawson DH, Crocker IR, Shelton Surgical treatment for brain metastases: prognostic factors and
JW, Melton A, Maynard N, Delman KA, Carlson GW, Rizzo M. survival in 177 patients. Neurosurg Rev 2005;28:115-9.
Prognostic factors for overall survival after radiosurgery for brain 65. Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW. Reevaluation
metastases from melanoma. Am J Clin Oncol 2014;37:580-4. of surgery for the treatment of brain metastases: review of 208 patients
50. Spanberger T, Berghoff AS, Dinhof C, Ilhan-Mutlu A, Magerle M, with single or multiple brain metastases treated at one institution with
Hutterer M, Pichler J, Wohrer A, Hackl M, Widhalm G, Hainfellner modern neurosurgical techniques. Neurosurgery 2005;56:1021-34;di
JA, Dieckmann K, Marosi C, Birner P, Prayer D, Preusser M. Extent scussion1021-34.
of peritumoral brain edema correlates with prognosis, tumoral 66. Gulati S, Jakola AS, Nerland US, Weber C, Solheim O. The
growth pattern, HIF1a expression and angiogenic activity in patients risk of getting worse: surgically acquired deficits, perioperative
with single brain metastases. Clin Exp Metastasis 2013;30:357-68. complications, and functional outcomes after primary resection of
51. Berghoff AS, Spanberger T, Ilhan-Mutlu A, Magerle M, Hutterer M, glioblastoma. World Neurosurg 2011;76:572-9.
Woehrer A, Hackl M, Widhalm G, Dieckmann K, Marosi C, Birner 67. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert
P, Prayer D, Preusser M. Preoperative diffusion-weighted imaging of BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel
single brain metastases correlates with patient survival times. PLoS M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L,
One 2013;8:e55464. Mueller RP. Adjuvant whole-brain radiotherapy versus observation
52. Zakaria R, Das K, Radon M, Bhojak M, Rudland PR, Sluming V, after radiosurgery or surgical resection of one to three cerebral
Jenkinson MD. Diffusion-weighted MRI characteristics of the metastases: results of the EORTC 22952-26001 study. J Clin Oncol
cerebral metastasis to brain boundary predicts patient outcomes. 2011;29:134-41.
BMC Med Imaging 2014;14:26. 68. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth
53. Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA.
Cobbs CS, Ammirati M, Robinson PD, Andrews DW, Loeffler JS, Neurocognition in patients with brain metastases treated with
McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, radiosurgery or radiosurgery plus whole-brain irradiation: a
Patchell RA, Ryken TC, Linskey ME. The role of surgical resection randomised controlled trial. Lancet Oncol 2009;10:1037-44.
in the management of newly diagnosed brain metastases: a systematic 69. Stockham AL, Ahluwalia M, Reddy CA, Suh JH, Kumar A,
review and evidence-based clinical practice guideline. J Neurooncol Vogelbaum MA, Barnett GH, Murphy ES, Chao ST. Results of
2010;96:33-43. a questionnaire regarding practice patterns for the diagnosis and
54. Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher treatment of intracranial radiation necrosis after SRS. J Neurooncol
B, Duncan G, Skingley P, Foster G, Levine M. A randomized trial to 2013;115:469-75.
assess the efficacy of surgery in addition to radiotherapy in patients 70. Momose T, Nariai T, Kawabe T, Inaji M, Tanaka Y, Watanabe S,
with a single cerebral metastasis. Cancer 1996;78:1470-6. Maehara T, Oda K, Ishii K, Ishiwata K, Yamamoto M. Clinical
55. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, benefit of 11C methionine PET imaging as a planning modality for
Hanssens PE, Schmitz PI. Identification of prognostic factors in radiosurgery of previously irradiated recurrent brain metastases. Clin
patients with brain metastases: a review of 1292 patients. Int J Radiat Nucl Med 2014;39:939-43.
Oncol Biol Phys 1999;43:795-803. 71. Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L,
56. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Swinnen LJ, Maria B, LaFollette S, Schumann GB, Cole BF, Howell
Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, SB. A randomized controlled trial comparing intrathecal sustained-

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ May 20, 2016 ¦ 173